In vitro experiments were performed to understand the effect of the inhibitor in human pancreatic cancer cells, including a cell growth inhibition assay, cell viability assay, cell cycle analysis, and analysis of the MAP4K4 regulated JNK/c-Jun signalling pathway. Here, JUN is linked to pancreatic neoplasm.